A consistent view of the latest supported company value and reported operating results.
Four transparent questions from retained financial evidence. Each result stands on its own; Grizzly Bulls does not combine them into a score, ranking, or recommendation.
Trailing-twelve-month net income is positive. As of 2026-06-26.
Trailing-twelve-month operating cash flow less capital expenditures is positive. As of 2026-06-26.
Reported current assets exceed reported current liabilities on the latest comparable retained balance sheet. As of 2026-06-26.
Comparable retained change history is not available through this reader.
Profitability uses only the sign of retained trailing-twelve-month net income. Cash generation uses only the sign of retained trailing-twelve-month free cash flow, defined as operating cash flow less capital expenditures.
Liquidity compares current assets with current liabilities only when both are retained for the same reporting date. It does not infer liquidity from differently dated balance sheets.
Recent operating direction uses the latest supported material financial event when comparable history exists. The existing change methodology requires at least a 10% absolute change or a sign/zero transition and compares quarterly results only with the same fiscal quarter year over year.
Completed-session reference prices from IEX for Oct 15, 2026.
IEX historical data reflects IEX activity only and is presented as a source-scoped reference point, not as consolidated U.S. market history. Prices are unadjusted. Price returns exclude dividends and are not total returns. Historical statistics appear only when the retained source-session chain is complete and no split-like share-basis discontinuity is detected for that calculation window.
Data provided for free by IEX. By accessing or using IEX Historical Data, you agree to the IEX Historical Data Terms of Use.
Five years of adjusted closing-price history for this listing, shown as historical context rather than a live quote.
The chart uses the market provider's adjusted daily close for the current listing. It does not stitch predecessor listings and does not represent total return, benchmark performance, or historical valuation.
Danaher is a global science and technology company whose operating businesses provide biotechnology, life sciences, and diagnostics instruments, consumables, software, and services.
Ticker: DHR · Exchange: NYSE · Danaher Common Stock
SEC issuer CIK: 0000313616
SEC-reported financial statement history with filing dates preserved. Annual view retains up to four fiscal years; quarterly view retains up to five fiscal quarters. Missing cells mean a supported fact is unknown and are not treated as zero.
| Metric | TTM · 2026-06-26 | FY 2025 · 2025-12-31 | FY 2025 · 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|---|
| Revenue | $25.11B Filed 2026-07-21 | $24.57B Filed 2026-02-24 | $23.88B Filed 2026-02-24 | $23.89B Filed 2026-02-24 | $26.64B Filed 2025-02-20 |
| Cost of revenue | $10.42B Filed 2026-07-21 | $10.05B Filed 2026-02-24 | $9.67B Filed 2026-02-24 | $9.86B Filed 2026-02-24 | $10.46B Filed 2025-02-20 |
| Gross profit | $14.69B Filed 2026-07-21 | $14.52B Filed 2026-02-24 | $14.21B Filed 2026-02-24 | $14.03B Filed 2026-02-24 | $16.19B Filed 2025-02-20 |
| Operating income | $5.13B Filed 2026-07-21 | $4.69B Filed 2026-02-24 | $4.86B Filed 2026-02-24 | $5.2B Filed 2026-02-24 | $7.54B Filed 2025-02-20 |
| Pretax income | $4.76B Filed 2026-07-21 | $4.23B Filed 2026-02-24 | $4.65B Filed 2026-02-24 | $5.04B Filed 2026-02-24 | $7.15B Filed 2025-02-20 |
| Income tax expense | $772M Filed 2026-07-21 | $633M Filed 2026-02-24 | $747M Filed 2026-02-24 | $823M Filed 2026-02-24 | $818M Filed 2025-02-20 |
| Net income | $4B Filed 2026-07-21 | $3.61B Filed 2026-02-24 | $3.9B Filed 2026-02-24 | $4.76B Filed 2026-02-24 | $7.21B Filed 2025-02-20 |
| Diluted EPS | Unavailable | $5.05 Filed 2026-02-24 | $5.29 Filed 2026-02-24 | $6.38 Filed 2026-02-24 | $9.66 Filed 2025-02-20 |
| Diluted shares | Unavailable | 716.1M Filed 2026-02-24 | 737.2M Filed 2026-02-24 | 743.1M Filed 2026-02-24 | 737.1M Filed 2025-02-20 |
| Metric | FY 2025 · 2025-12-31 | FY 2025 · 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Current assets | $12.76B Filed 2026-02-24 | $9.5B Filed 2026-02-24 | $13.94B Filed 2025-02-20 | $15.88B Filed 2024-02-21 |
| Current liabilities | $6.81B Filed 2026-02-24 | $6.8B Filed 2026-02-24 | $8.27B Filed 2025-02-20 | $8.39B Filed 2024-02-21 |
| Long-term debt, noncurrent | $18.42B Filed 2026-02-24 | $15.5B Filed 2026-02-24 | $16.71B Filed 2025-02-20 | $19.09B Filed 2024-02-21 |
| Total assets | $83.46B Filed 2026-02-24 | $77.54B Filed 2026-02-24 | $84.49B Filed 2026-02-24 | $84.35B Filed 2025-02-20 |
| Stockholders’ equity | $52.53B Filed 2026-02-24 | $49.54B Filed 2026-02-24 | $53.49B Filed 2025-02-20 | $50.08B Filed 2024-02-21 |
| Metric | TTM · 2026-06-26 | FY 2025 · 2025-12-31 | FY 2025 · 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|---|
| Operating cash flow | $6.64B Filed 2026-07-21 | $6.42B Filed 2026-02-24 | $6.69B Filed 2026-02-24 | $7.16B Filed 2026-02-24 | $8.52B Filed 2025-02-20 |
| Depreciation & amortization | Unknown | Unknown | Unknown | $2.17B Filed 2024-02-21 | $2.13B Filed 2024-02-21 |
| Capital expenditures | $1.17B Filed 2026-07-21 | $1.16B Filed 2026-02-24 | $1.39B Filed 2026-02-24 | $1.38B Filed 2026-02-24 | $1.12B Filed 2025-02-20 |
| Dividends paid | $964M Filed 2026-07-21 | $878M Filed 2026-02-24 | $768M Filed 2026-02-24 | $821M Filed 2026-02-24 | $818M Filed 2025-02-20 |
| Stock repurchases | $2.9B Filed 2026-07-21 | $3.09B Filed 2026-02-24 | $5.98B Filed 2026-02-24 | $0 Filed 2026-02-24 | $0 Filed 2025-02-20 |
Source: SEC filings. Financial facts retain filing dates and are shown only when the retained source and period alignment support them.
Reference valuation uses the latest retained completed-session IEX close and the latest supported SEC-reported share count for a simple single ordinary-share structure.
Open this stock in the Valuation Lab →
Shares outstanding: 702.99M · reported as of 2026-07-16 · filed 2026-07-21
The price is a source-scoped IEX reference close, not a consolidated U.S. market close. P/E and enterprise-value multiples are omitted unless compatible common-equity earnings and complete financing scope are established rather than inferred from adjacent statement fields.
Reproducible trailing, quarterly, and annual statistics from retained SEC financials. Growth and return measures appear only when the required reporting periods align; missing denominators are omitted rather than estimated.
Trailing, quarterly, and annual profitability, return, and growth measures derived from retained SEC financials.
Latest annual liquidity measures using same-period reported current assets and current liabilities.
Trailing cash generation plus latest annual dividends and share repurchases where reported.
Historical financial statistics are descriptive accounting measures, not rankings or investment recommendations.
No reviewed company-level insider ownership record is available for this listing.
Deterministic changes from supported reported financials, reviewed share-count history, and comparable reviewed ownership records. Events are ordered by when the supporting information became public, not by a Grizzly Bulls importance score.
Primary evidence: 10-Q · Apr 21, 2026 · 10-Q · Jul 21, 2026
Comparison evidence: 10-Q · Apr 22, 2025 · 10-Q · Jul 22, 2025
Primary evidence: 10-K · Feb 24, 2026
Comparison evidence: 10-K · Feb 24, 2026
Primary evidence: 10-K · Feb 24, 2026
Comparison evidence: 10-K · Feb 20, 2025
Primary evidence: 10-Q · Jul 22, 2025 · 10-Q · Oct 21, 2025
Comparison evidence: 10-Q · Jul 23, 2024 · 10-Q · Oct 22, 2024
Primary evidence: 10-Q · Jul 22, 2025
Comparison evidence: 10-Q · Jul 23, 2024
Primary evidence: 10-Q · Apr 22, 2025
Comparison evidence: 10-Q · Apr 23, 2024
Primary evidence: 10-K · Feb 20, 2025
Comparison evidence: 10-K · Feb 21, 2024
Primary evidence: 10-Q · Oct 22, 2024
Comparison evidence: 10-Q · Oct 24, 2023
Financial-result events require at least a 10% absolute change or a sign/zero transition in supported revenue, operating income, net income, or free cash flow. Quarterly comparisons are same fiscal quarter year over year; annual comparisons use adjacent comparable annual periods.
Share-count events use only consecutive reviewed complete share-count observations. Ownership events require explicit comparable complete beneficial-ownership snapshots; partial incremental ownership reports are never treated as complete positions.
This is a structured change feed, not a general news feed or generated factual narrative. Missing source history can mean that a change is not measurable here.
Margins and growth rates are calculated from the reported financial results shown on this page.
Reviewed issuer filings from SEC EDGAR. Current reports show filed SEC item categories rather than generated news summaries.
